PMC4344169_01
Schematic representation of the lab parameters course of the patient treated with rituximab for his AHA.
mjhid-7-1-e2015024f1.jpg
PMC4344169_01_mjhid-7-1-e2015024f1.jpg
f1-mjhid-7-1-e2015024
Prednisone was then reintroduced at the dose of 1 mg/Kg and Rituximab given for 3 additional infusions, with normalization of aPTT and disappearance of inhibitor since a week after the eighth Rituximab infusion (Figure 1).